Arabic Translation and Validation of the IBD-Control Questionnaire in Patients With Inflammatory Bowel Disease (ACG 2026) - Aug 29, 2026 - Abstract #P1200; Pres time: Oct 11, 2026; 03:30 PM - 07:00 PM; Location: Exhibit Halls A - D (Level 3); "Figure: IQR, interquartile range; CD, Crohnâs disease; UC, ulcerative colitis; HBI, Harvey-Bradshaw Index; CRP, C-reactive protein; FCP, fecal calprotectin; AZA, azathioprine; 6-MP, 6-mercaptopurine; CZP, certolizumab pegol; IFX, infliximab; VDZ, vedolizumab; UST, ustekinumab; RZB, risankizumab; TOFA, tofacitinib; UPA, upadacitinib; PSQI, Pittsburgh Sleep Quality Index; HADS, Hospital Anxiety and Depression Scale; FACIT-F, Functional Assessment of Chronic Illness TherapyâFatigue; VAS, visual analogue scale. A total of 203 patients completed the Arabic IBD-CQ (median age 31, 40.9% female, 70.0% CD) (Table 1) completed the Arabic IBD-CQ. The Arabic IBD-CQ demonstrated excellent internal consistency (Cronbach's α=0.820); all 8 items had corrected item-total râ¥0.44, and no item improved α if deleted. Construct validity was strong with expected-direction correlations: FACIT-F..."
Clinical • CNS Disorders • Crohn's disease • Depression • Gastroenterology • Gastrointestinal Disorder • Immunology • Inflammation • Inflammatory Bowel Disease • Mood Disorders • Ulcerative Colitis • CRP
|
|
Salman Almuammar MBBS 1; Muath Alanazi MBBS 1; Naif Alrossais MD 1; Haneen Abu Raida MBBS 2; Samhar Alouch 2; Abdul Razzak Chalab Cham MBBS 2; Mohamed Naim Khalil MBBS 2; Abdulelah Almutairdi MD 1; Mashary Attamimi MD 1; Badr Al-Bawardy MBBS 1
|